{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:08:53Z","timestamp":1790914133378,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-15-003-01-CCE"],"award-info":[{"award-number":["RSG-15-003-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P50CA211015-01A1"],"award-info":[{"award-number":["1P50CA211015-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA223757-01"],"award-info":[{"award-number":["1R21CA223757-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00234-020-02585-8","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T19:02:32Z","timestamp":1603738952000},"page":"857-868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas"],"prefix":"10.1007","volume":"63","author":[{"given":"Talia C.","family":"Oughourlian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney B.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phioanh L.","family":"Nghiemphu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Liau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-6640","authenticated-orcid":false,"given":"Benjamin M.","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"issue":"6","key":"2585_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2585_CR2","doi-asserted-by":"publisher","first-page":"e16146","DOI":"10.1371\/journal.pone.0016146","volume":"6","author":"N Shah","year":"2011","unstructured":"Shah N, Lin B, Sibenaller Z, Ryken T, Lee H, Yoon JG, Rostad S, Foltz G (2011) Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One 6(1):e16146. https:\/\/doi.org\/10.1371\/journal.pone.0016146","journal-title":"PLoS One"},{"issue":"5","key":"2585_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11910-013-0345-4","volume":"13","author":"AL Cohen","year":"2013","unstructured":"Cohen AL, Holmen SL, Colman H (2013) IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep 13(5):345. https:\/\/doi.org\/10.1007\/s11910-013-0345-4","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"2585_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00701-016-2928-8","volume":"158","author":"CP Millward","year":"2016","unstructured":"Millward CP, Brodbelt AR, Haylock B, Zakaria R, Baborie A, Crooks D, Husband D, Shenoy A, Wong H, Jenkinson MD (2016) The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy. Acta Neurochir 158(10):1943\u20131953. https:\/\/doi.org\/10.1007\/s00701-016-2928-8","journal-title":"Acta Neurochir"},{"issue":"17","key":"2585_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1212\/WNL.0b013e3182a95680","volume":"81","author":"W Wick","year":"2013","unstructured":"Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M (2013) Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology 81(17):1515\u20131522. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a95680","journal-title":"Neurology"},{"issue":"21","key":"2585_CR6","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1212\/01.wnl.0000262034.26310.a2","volume":"68","author":"G Kaloshi","year":"2007","unstructured":"Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K (2007) Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome. Neurology 68(21):1831\u20131836. https:\/\/doi.org\/10.1212\/01.wnl.0000262034.26310.a2","journal-title":"Neurology"},{"issue":"10","key":"2585_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/neuonc\/nox078","volume":"19","author":"A Aibaidula","year":"2017","unstructured":"Aibaidula A, Chan AK, Shi Z, Li Y, Zhang R, Yang R, Li KK, Chung NY, Yao Y, Zhou L, Wu J, Chen H, Ng HK (2017) Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro-Oncology 19(10):1327\u20131337. https:\/\/doi.org\/10.1093\/neuonc\/nox078","journal-title":"Neuro-Oncology"},{"issue":"5","key":"2585_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for \"diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\". Acta Neuropathol 136(5):805\u2013810. https:\/\/doi.org\/10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol"},{"issue":"13","key":"2585_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.0000000000000814","volume":"83","author":"M Labussiere","year":"2014","unstructured":"Labussiere M, Boisselier B, Mokhtari K, Di Stefano AL, Rahimian A, Rossetto M, Ciccarino P, Saulnier O, Paterra R, Marie Y, Finocchiaro G, Sanson M (2014) Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes. Neurology 83(13):1200\u20131206. https:\/\/doi.org\/10.1212\/WNL.0000000000000814","journal-title":"Neurology"},{"issue":"3","key":"2585_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-015-1454-8","volume":"130","author":"DE Reuss","year":"2015","unstructured":"Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, Hovestadt V, Bewerunge-Hudler M, Jones DT, Schittenhelm J, Mittelbronn M, Rushing E, Simon M, Westphal M, Unterberg A, Platten M, Paulus W, Reifenberger G, Tonn JC, Aldape K, Pfister SM, Korshunov A, Weller M, Herold-Mende C, Wick W, Brandner S, von Deimling A (2015) Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathol 130(3):407\u2013417. https:\/\/doi.org\/10.1007\/s00401-015-1454-8","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2585_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5301\/ijbm.5000301","volume":"33","author":"FS Saadeh","year":"2018","unstructured":"Saadeh FS, Mahfouz R, Assi HI (2018) EGFR as a clinical marker in glioblastomas and other gliomas. Int J Biol Markers 33(1):22\u201332. https:\/\/doi.org\/10.5301\/ijbm.5000301","journal-title":"Int J Biol Markers"},{"issue":"5","key":"2585_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00401-013-1101-1","volume":"125","author":"KM Talasila","year":"2013","unstructured":"Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PO, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mork SJ, Enger PO, Bjerkvig R, Miletic H (2013) EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol 125(5):683\u2013698. https:\/\/doi.org\/10.1007\/s00401-013-1101-1","journal-title":"Acta Neuropathol"},{"issue":"32","key":"2585_CR13","doi-asserted-by":"publisher","first-page":"13092","DOI":"10.1073\/pnas.0702387104","volume":"104","author":"A Franovic","year":"2007","unstructured":"Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S (2007) Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci U S A 104(32):13092\u201313097. https:\/\/doi.org\/10.1073\/pnas.0702387104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2585_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mrm.21108","volume":"57","author":"X He","year":"2007","unstructured":"He X, Yablonskiy DA (2007) Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med 57(1):115\u2013126. https:\/\/doi.org\/10.1002\/mrm.21108","journal-title":"Magn Reson Med"},{"issue":"4","key":"2585_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1073\/pnas.22.4.210","volume":"22","author":"L Pauling","year":"1936","unstructured":"Pauling L, Coryell CD (1936) The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc Natl Acad Sci U S A 22(4):210\u2013216. https:\/\/doi.org\/10.1073\/pnas.22.4.210","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2585_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.mri.2014.08.027","volume":"32","author":"AM Stokes","year":"2014","unstructured":"Stokes AM, Skinner JT, Quarles CC (2014) Assessment of a combined spin- and gradient-echo (SAGE) DSC-MRI method for preclinical neuroimaging. Magn Reson Imaging 32(10):1181\u20131190. https:\/\/doi.org\/10.1016\/j.mri.2014.08.027","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"2585_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mrm.23195","volume":"68","author":"H Schmiedeskamp","year":"2012","unstructured":"Schmiedeskamp H, Straka M, Newbould RD, Zaharchuk G, Andre JB, Olivot JM, Moseley ME, Albers GW, Bammer R (2012) Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med 68(1):30\u201340. https:\/\/doi.org\/10.1002\/mrm.23195","journal-title":"Magn Reson Med"},{"issue":"10","key":"2585_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.mri.2014.08.032","volume":"32","author":"JT Skinner","year":"2014","unstructured":"Skinner JT, Robison RK, Elder CP, Newton AT, Damon BM, Quarles CC (2014) Evaluation of a multiple spin- and gradient-echo (SAGE) EPI acquisition with SENSE acceleration: applications for perfusion imaging in and outside the brain. Magn Reson Imaging 32(10):1171\u20131180. https:\/\/doi.org\/10.1016\/j.mri.2014.08.032","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"2585_CR19","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mrm.25232","volume":"73","author":"W Ni","year":"2015","unstructured":"Ni W, Christen T, Zun Z, Zaharchuk G (2015) Comparison of R2' measurement methods in the normal brain at 3 tesla. Magn Reson Med 73(3):1228\u20131236. https:\/\/doi.org\/10.1002\/mrm.25232","journal-title":"Magn Reson Med"},{"issue":"7","key":"2585_CR20","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1161\/01.STR.0000226738.97426.6f","volume":"37","author":"BS Geisler","year":"2006","unstructured":"Geisler BS, Brandhoff F, Fiehler J, Saager C, Speck O, Rother J, Zeumer H, Kucinski T (2006) Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 37(7):1778\u20131784. https:\/\/doi.org\/10.1161\/01.STR.0000226738.97426.6f","journal-title":"Stroke"},{"issue":"7","key":"2585_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/1747493017706221","volume":"12","author":"U Jensen-Kondering","year":"2017","unstructured":"Jensen-Kondering U, Manavaki R, Ejaz S, Sawiak SJ, Carpenter TA, Fryer TD, Aigbirhio FI, Williamson DJ, Baron JC (2017) Brain hypoxia mapping in acute stroke: back-to-back T2' MR versus (18)F-fluoromisonidazole PET in rodents. Int J Stroke 12(7):752\u2013760. https:\/\/doi.org\/10.1177\/1747493017706221","journal-title":"Int J Stroke"},{"issue":"2","key":"2585_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11060-013-1210-7","volume":"115","author":"V Toth","year":"2013","unstructured":"Toth V, Forschler A, Hirsch NM, den Hollander J, Kooijman H, Gempt J, Ringel F, Schlegel J, Zimmer C, Preibisch C (2013) MR-based hypoxia measures in human glioma. J Neuro-Oncol 115(2):197\u2013207. https:\/\/doi.org\/10.1007\/s11060-013-1210-7","journal-title":"J Neuro-Oncol"},{"key":"2585_CR23","doi-asserted-by":"publisher","unstructured":"Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM (2019) Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro-Oncology. https:\/\/doi.org\/10.1093\/neuonc\/noz078","DOI":"10.1093\/neuonc\/noz078"},{"issue":"3","key":"2585_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mrm.23283","volume":"68","author":"T Christen","year":"2012","unstructured":"Christen T, Schmiedeskamp H, Straka M, Bammer R, Zaharchuk G (2012) Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach. Magn Reson Med 68(3):905\u2013911. https:\/\/doi.org\/10.1002\/mrm.23283","journal-title":"Magn Reson Med"},{"issue":"8","key":"2585_CR25","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/00004647-200008000-00008","volume":"20","author":"H An","year":"2000","unstructured":"An H, Lin W (2000) Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 20(8):1225\u20131236. https:\/\/doi.org\/10.1097\/00004647-200008000-00008","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2585_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/jcbfm.2014.187","volume":"35","author":"AP Fan","year":"2015","unstructured":"Fan AP, Govindarajan ST, Kinkel RP, Madigan NK, Nielsen AS, Benner T, Tinelli E, Rosen BR, Adalsteinsson E, Mainero C (2015) Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis. J Cereb Blood Flow Metab 35(1):131\u2013139. https:\/\/doi.org\/10.1038\/jcbfm.2014.187","journal-title":"J Cereb Blood Flow Metab"},{"issue":"34","key":"2585_CR27","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29(34):4482\u20134490. https:\/\/doi.org\/10.1200\/JCO.2010.33.8715","journal-title":"J Clin Oncol"},{"issue":"3","key":"2585_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.lab.0000059948.67795.ef","volume":"83","author":"KJ Hatanpaa","year":"2003","unstructured":"Hatanpaa KJ, Burger PC, Eshleman JR, Murphy KM, Berg KD (2003) Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Investig 83(3):419\u2013428. https:\/\/doi.org\/10.1097\/01.lab.0000059948.67795.ef","journal-title":"Lab Investig"},{"issue":"6","key":"2585_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00004424-199906000-00007","volume":"34","author":"O Tynninen","year":"1999","unstructured":"Tynninen O, Aronen HJ, Ruhala M, Paetau A, Von Boguslawski K, Salonen O, Jaaskelainen J, Paavonen T (1999) MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. Investig Radiol 34(6):427\u2013434. https:\/\/doi.org\/10.1097\/00004424-199906000-00007","journal-title":"Investig Radiol"},{"issue":"9","key":"2585_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/neuonc\/nov095","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering C (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro-Oncology 17(9):1188\u20131198. https:\/\/doi.org\/10.1093\/neuonc\/nov095","journal-title":"Neuro-Oncology"},{"issue":"6","key":"2585_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3174\/ajnr.A6063","volume":"40","author":"YL Wang","year":"2019","unstructured":"Wang YL, Yao J, Chakhoyan A, Raymond C, Salamon N, Liau LM, Nghiemphu PL, Lai A, Pope WB, Nguyen N, Ji M, Cloughesy TF, Ellingson BM (2019) Association between tumor acidity and hypervascularity in human gliomas using pH-weighted amine chemical exchange saturation transfer echo-planar imaging and dynamic susceptibility contrast perfusion MRI at 3T. AJNR Am J Neuroradiol 40(6):979\u2013986. https:\/\/doi.org\/10.3174\/ajnr.A6063","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"2585_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/neuonc\/now187","volume":"19","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro-Oncology 19(1):89\u201398. https:\/\/doi.org\/10.1093\/neuonc\/now187","journal-title":"Neuro-Oncology"},{"issue":"3","key":"2585_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/neuonc\/not198","volume":"16","author":"AN Tran","year":"2014","unstructured":"Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM (2014) Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro-Oncology 16(3):414\u2013420. https:\/\/doi.org\/10.1093\/neuonc\/not198","journal-title":"Neuro-Oncology"},{"issue":"1","key":"2585_CR34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/radiol.13131305","volume":"271","author":"BM Ellingson","year":"2014","unstructured":"Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271(1):200\u2013210. https:\/\/doi.org\/10.1148\/radiol.13131305","journal-title":"Radiology"},{"issue":"9","key":"2585_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1593\/neo.10688","volume":"12","author":"KJ Hatanpaa","year":"2010","unstructured":"Hatanpaa KJ, Burma S, Zhao D, Habib AA (2010) Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 12(9):675\u2013684. https:\/\/doi.org\/10.1593\/neo.10688","journal-title":"Neoplasia"},{"issue":"8","key":"2585_CR36","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3174\/ajnr.A4759","volume":"37","author":"K Leu","year":"2016","unstructured":"Leu K, Boxerman JL, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB, Ellingson BM (2016) Improved leakage correction for single-echo dynamic susceptibility contrast perfusion MRI estimates of relative cerebral blood volume in high-grade gliomas by accounting for bidirectional contrast agent exchange. AJNR Am J Neuroradiol 37(8):1440\u20131446. https:\/\/doi.org\/10.3174\/ajnr.A4759","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"2585_CR37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/mrm.1910320610","volume":"32","author":"DA Yablonskiy","year":"1994","unstructured":"Yablonskiy DA, Haacke EM (1994) Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 32(6):749\u2013763. https:\/\/doi.org\/10.1002\/mrm.1910320610","journal-title":"Magn Reson Med"},{"issue":"1","key":"2585_CR38","doi-asserted-by":"publisher","first-page":"E98","DOI":"10.1016\/j.ijrobp.2019.06.2287","volume":"105","author":"M Goldstein","year":"2019","unstructured":"Goldstein M, Rudra S, Dahiya S, Tsien C, Huang J (2019) Prognostic value of EGFR amplification in glioblastoma patients treated with radiation therapy and concurrent temozolomide. Int J Radiat Oncol Biol Phys 105(1):E98\u2013E99","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2585_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","volume":"44","author":"L Bekaert","year":"2017","unstructured":"Bekaert L, Valable S, Lechapt-Zalcman E, Ponte K, Collet S, Constans JM, Levallet G, Bordji K, Petit E, Branger P, Emery E, Manrique A, Barre L, Bernaudin M, Guillamo JS (2017) [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. Eur J Nucl Med Mol Imaging 44(8):1383\u20131392. https:\/\/doi.org\/10.1007\/s00259-017-3677-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2585_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1148\/radiol.2020191711","volume":"295","author":"D Paech","year":"2020","unstructured":"Paech D, Nagel AM, Schultheiss MN, Umathum R, Regnery S, Scherer M, Wick A, Platt T, Wick W, Bendszus M, Unterberg A, Schlemmer HP, Ladd ME, Niesporek SC (2020) Quantitative dynamic oxygen 17 MRI at 7.0 T for the cerebral oxygen metabolism in glioma. Radiology 295(1):181\u2013189. https:\/\/doi.org\/10.1148\/radiol.2020191711","journal-title":"Radiology"},{"issue":"6","key":"2585_CR41","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ccr.2011.11.005","volume":"20","author":"M Snuderl","year":"2011","unstructured":"Snuderl M, Fazlollahi L, Le LP, Nitta M, Zhelyazkova BH, Davidson CJ, Akhavanfard S, Cahill DP, Aldape KD, Betensky RA, Louis DN, Iafrate AJ (2011) Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20(6):810\u2013817. https:\/\/doi.org\/10.1016\/j.ccr.2011.11.005","journal-title":"Cancer Cell"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-020-02585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-020-02585-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-020-02585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T20:30:45Z","timestamp":1635193845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-020-02585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2585"],"URL":"https:\/\/doi.org\/10.1007\/s00234-020-02585-8","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ellingson\u2014Advisory Board\u2014Hoffman La-Roche; Siemens; Nativis; Medicenna; MedQIA; Bristol Meyers Squibb; Imaging Endpoints; Agios. Paid Consultant\u2014Nativis; MedQIA; Siemens; Hoffman La-Roche; Imaging Endpoints; Medicenna; Agios. Grant Funding\u2014Hoffman La-Roche; Siemens; Agios; Janssen. Dr. Ellingson also holds a patent on this technology (US Patent #15\/577,664; International PCT\/US2016\/034886).Cloughesy\u2014Advisory Board\u2013 Roche\/Genentech, Amgen, Tocagen, NewGen, LPath, Proximagen, Celgene, Vascular Biogenics Ltd, Insys, Agios, Cortice Bioscience, Pfizer, Human Longevity, BMS, Merck, Notable Lab, MedQIA.Nathanson\u2014 Co-Founder of Katmai Pharmaceuticals, Consultant of Katmai Pharmaceuticals, Co-Founder of Trethera Corporation, Shareholder in Sofie Biosciences.Oughourlian\u2014None related to this study.Yao\u2014None related to this study.Hagiwara\u2014None related to this study.Raymond\u2014None related to this study.Pope\u2014None related to this study.Salamon\u2014None related to this study.Lai\u2014None related to this study.Ji\u2014None related to this study.Nghiemphu\u2014None related to this study.Liau\u2014None related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in reports involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants before evaluation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}